Showing results (171-180 of 384) with videos related to

Sort By:
Pageof 39
Critical Reviews in Oncology/Hematology|June 13, 2017
Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapyNabil F Saba, Mayur D Mody, Elaine S Tan, et al.
Biomedicines|August 26, 2022
Chromosome Translocations, Gene Fusions, and Their Molecular Consequences in Pleomorphic Salivary Gland AdenomasGöran Stenman, Andre Fehr, Alena Skálová, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinomaAnne W M Lee, Victor H F Lee, Wai-Tong Ng, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 10, 2009
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinomaNabil F Saba, Misun Choi, Susan Muller, et al.
Head & Neck|April 23, 2015
Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapySheela Hanasoge, Kelly R Magliocca, Jeffrey M Switchenko, et al.
Biomedicines|March 29, 2023
Radiomics in Hypopharyngeal Cancer Management: A State-of-the-Art ReviewCarlos M Chiesa-Estomba, Miguel Mayo-Yanez, Orlando Guntinas-Lichius, et al.
AJNR. American Journal of Neuroradiology|April 2, 2017
Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell CarcinomaD A Krieger, P A Hudgins, G K Nayak, et al.
Veterinary and Comparative Oncology|September 12, 2017
Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different dosesC F Saba, K R Vickery, C A Clifford, et al.
JCO Oncology Practice|February 13, 2020
Demographic and Socioeconomic Factors Associated With Metastases at Presentation in HPV-Related Squamous Cell Carcinoma of the Head and Neck: An NCDB AnalysisMarta B Bean, Jeffrey M Switchenko, Conor Ernst Steuer, et al.
Oral Oncology|October 26, 2021
Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC)Lihua Shu, Dongsheng Wang, Sreenivas Nannapaneni, et al.
Pageof 39